Kontinuierliche Nierenersatztherapie

ZUSAMMENFASSUNG

Zusammenfassend stellt die kontinuierliche Nierenersatztherapie (CKRT: „continuous kidney replacement therapy“) eine sichere Option der Nierenersatztherapie (KRT) dar. Durch die lokale Wirksamkeit der zitratbasierten Antikoagulation wird eine systemische Antikoagulation vermieden und das Blutungsrisiko reduziert. Ebenso ermöglicht die Verwendung der regionalen Antikoagulation eine unkomplizierte Anpassung an spezifische klinische Gegebenheiten. Dennoch ist es wichtig, den Elektrolythaushalt während der CKRT sorgfältig zu überwachen, um potenzielle Überdosierungen und mögliche Komplikationen zu minimieren sowie die Effektivität des Verfahrens zu gewährleisten. In diesem Artikel geben wir einen Überblick über die am häufigsten auftretenden Komplikationen während der CKRT-Anwendung, wobei der Fokus auf der Optimierung und Fehlerbehebung von Antikoagulation und Elektrolytstörungen liegt – letztlich Faktoren, die die Sicherheit und Effektivität des Verfahrens maßgeblich definieren.

Publikationsverlauf

Artikel online veröffentlicht:
25. Juni 2024

• Literatur

• 1 Kramer P, Wigger W, Rieger J. et al [Arteriovenous haemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics]. Klin Wochenschr 1977; 55: 1121-1122
• 2 Neyra JA, Yessayan L, Thompson Bastin ML. et al How to prescribe and troubleshoot continuous renal replacement therapy: a case-based review. Kidney360 2020; 02: 371-384
• 3 Bell M, SWING Granath F. et al Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med 2007; 33: 773-780
• 4 Wang AY, Bellomo R. Renal replacement therapy in the ICU: intermittent hemodialysis, sustained low-efficiency dialysis or continuous renal replacement therapy?. Curr Opin Crit Care 2018; 24: 437-442
• 5 Wald R, Shariff SZ, Adhikari NK. et al The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study. Crit Care Med 2014; 42: 868-877
• 6 Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; 02: 1-138
• 7 Neyra JA, Goldstein SL. Optimizing renal replacement therapy deliverables through multidisciplinary work in the intensive care unit. Clin Nephrol 2018; 90: 1-5
• 8 Rewa OG, Villeneuve PM, Lachance P. et al Quality indicators of continuous renal replacement therapy (CRRT) care in critically ill patients: a systematic review. Intensive Care Med 2017; 43: 750-763
• 9 Ronco C, Bellomo R. Acute renal failure in patients with kidney transplant: continuous versus intermittent renal replacement therapy. Ren Fail 1996; 18: 461-470
• 10 Ronco C, Ricci Z. Renal replacement therapies: physiological review. Intensive Care Med 2008; 34: 2139-2146
• 11 Joannidis M, Oudemans-van Straaten HM. Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care 2007; 11: 218
• 12 Uchino S, Bellomo R, Morimatsu H. et al Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B. E. S. T. kidney) investigators. Intensive Care Med 2007; 33: 1563-1570
• 13 Hetzel GR, Schmitz M, Wissing H. et al Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant 2011; 26: 232-239
• 14 Bai M, Zhou M, He L. et al Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med 2015; 41: 2098-2110
• 15 Gattas DJ, Rajbhandari D, Bradford C. et al A randomized controlled trial of regional citrate versus regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults. Crit Care Med 2015; 43: 1622-1629
• 16 Oudemans-van Straaten HM, Bosman RJ, Koopmans M. et al Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009; 37: 545-552
• 17 Schilder L, Nurmohamed SA, Bosch FH. et al Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial. Crit Care 2014; 18: 472
• 18 Stucker F, Ponte B, Tataw J. et al Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. Crit Care 2015; 19: 91
• 19 Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med 2012; 38: 20-28
• 20 Zarbock A, Kullmar M, Kindgen-Milles D. et al Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial. JAMA 2020; 324: 1629-1639
• 21 Jacobs R, Honore PM, Hendrickx I. et al Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy:. All Citrates Are Not Created Equal! Blood Purif 2016; 42: 219-220
• 22 Meier-Kriesche HU, Gitomer J, Finkel K. et al Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001; 29: 748-752
• 23 Schultheiß C, Saugel B, Phillip V. et al Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care 2012; 16: R162
• 24 Honore PM, Mugisha A, David C. et al In severe liver disease, citrate can be used safely: the question remains-by which mechanism. Crit Care 2020; 24: 63
• 25 Klingele M, Stadler T, Fliser D. et al Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction. Crit Care 2017; 21: 294
• 26 Slowinski T, Morgera S, Joannidis M. et al Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care 2015; 19: 349
• 27 Khadzhynov D, Dahlinger A, Schelter C. et al Hyperlactatemia, lactate kinetics and prediction of citrate accumulation in critically ill patients undergoing continuous renal replacement therapy with regional citrate anticoagulation. Crit Care Med 2017; 45: e941-e946
• 28 Vandiver JW, Vondracek TG. Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin. Pharmacotherapy 2012; 32: 546-558
• 29 Endres P, Rosovsky R, Zhao S. et al Filter clotting with continuous renal replacement therapy in COVID-19. J Thromb Thrombolysis 2021; 51: 966-970
• 30 Dingman JS, Smith ZR, Coba VE. et al Argatroban dosing requirements in extracorporeal life support and other critically ill populations. Thromb Res 2020; 189: 69-76
• 31 Keegan SP, Gallagher EM, Ernst NE. et al Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia. Ann Pharmacother 2009; 43: 19-27
• 32 Shankaranarayanan D, Muthukumar T, Barbar T. et al Anticoagulation strategies and filter life in COVID-19 patients receiving continuous renal replacement therapy: a single-center experience. Clin J Am Soc Nephrol 2020; 16: 124-12
• 33 Valle EO, Cabrera CPS, Albuquerque CCC. et al Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study. Crit Care 2021; 25: 299
• 34 Nash DM, Przech S, Wald R. et al Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J Crit Care 2017; 41: 138-144
• 35 Schneider AG, Journois D, Rimmele T. Complications of regional citrate anticoagulation: accumulation or overload?. Crit Care 2017; 21: 281
• 36 Morgera S, Schneider M, Slowinski T. et al A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 2009; 37: 2018-2024
• 37 Davenport A, Tolwani A. Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. NDT Plus 2009; 02: 439-447
• 38 Zheng Y, Zhuang F, Zhu Q. et al Albumin-corrected total/ionized calcium ratio is not superior to total/ionized calcium ratio as an indicator of citrate accumulation. Int J Artif Organs 2017; 40: 602-606
• 39 Tan JN, Haroon SWP, Mukhopadhyay A. et al Hyperlactatemia predicts citrate intolerance with regional citrate anticoagulation during continuous renal replacement therapy. J Intensive Care Med 2019; 34: 418-425
• 40 Zhang W, Bai M, Yu Y. et al Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis. Crit Care 2019; 23: 22
• 41 Tan HK, Baldwin I, Bellomo R. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 2000; 26: 1652-1657
• 42 Parienti JJ, Megarbane B, Fischer MO. et al Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med 2010; 38: 1118-1125
• 43 Morgera S, Scholle C, Voss G. et al Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron Clin Pract 2004; 97: c131-c136
• 44 Morgera S, Haase M, Ruckert M. et al Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis. Nephron Clin Pract 2005; 101: c211-c219
• 45 Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med 2000; 342: 1493-1499
• 46 Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342: 1581-1589
• 47 Ostermann M, Dickie H, Tovey L. et al Management of sodium disorders during continuous haemofiltration. Crit Care 2010; 14: 418
• 48 Huang WY, Weng WC, Peng TI. et al Central pontine and extrapontine myelinolysis after rapid correction of hyponatremia by hemodialysis in a uremic patient. Ren Fail 2007; 29: 635-638
• 49 Peces R, Ablanedo P, Alvarez J. et al Central pontine and extrapontine myelinolysis following correction of severe hyponatremia. Nephron 1988; 49: 160-163
• 50 Yessayan L, Yee J, Frinak S. et al Treatment of severe hyponatremia in patients with kidney failure: role of continuous venovenous hemofiltration with low-sodium replacement fluid. Am J Kidney Dis 2014; 64: 305-310
• 51 Paquette F, Goupil R, Madore F. et al Continuous venovenous hemofiltration using customized replacement fluid for acute kidney injury with severe hypernatremia. Clin Kidney J 2016; 09: 540-542
• 52 Neyra JA, Ortiz-Soriano VM, Ali D. et al A multidisciplinary approach for the management of severe hyponatremia in patients requiring continuous renal replacement therapy. Kidney Int Rep 2019; 04: 59-66
• 53 Yessayan L, Yee J, Frinak S. et al Continuous renal replacement therapy for the management of acid-base and electrolyte imbalances in acute kidney injury. Adv Chronic Kidney Dis 2016; 23: 203-210
• 54 Geerse DA, Bindels AJ, Kuiper MA. et al Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care 2010; 14: R147
• 55 Heung M, Mueller BA. Prevention of hypophosphatemia during continuous renal replacement therapy – An overlooked problem. Semin Dial 2018; 31: 213-218
• 56 Broman M, Carlsson O, Friberg H. et al Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy. Acta Anaesthesiol Scand 2011; 55: 39-45
• 57 Aubier M, Murciano D, Lecocguic Y. et al Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure. N Engl J Med 1985; 313: 420-424
• 58 Demirjian S, Teo BW, Guzman JA. et al Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant 2011; 26: 3508-3514
• 59 Yang Y, Zhang P, Cui Y. et al Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury. Crit Care 2013; 17: R205
• 60 Thompson Bastin ML, Stromberg AJ, Nerusu SN. et al Association of phosphate-containing versus phosphate-free solutions on ventilator days in patients requiring continuous kidney replacement therapy. Clin J Am Soc Nephrol 2022; 17: 634-642